Literature DB >> 10782082

Giardia vaccination.

M E Olson1, H Ceri, D W Morck.   

Abstract

Recently, a Giardia vaccine has become commercially available in the USA for prevention of clinical signs of giardiasis and reduction of cyst shedding in dogs and cats. The vaccine is based upon the current state of knowledge of Giardia antigenicity and immunology. Here, Merle Olson, Howard Ceri and Douglas Morck describe studies that led to the development of this vaccine and subsequent efficacy studies. Immunoprophylaxis and immunotherapeutic application of the vaccine are discussed.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10782082     DOI： 10.1016/s0169-4758(99)01623-3

Source DB:  PubMed          Journal:  Parasitol Today        ISSN： 0169-4758


  25 in total

1.  Identification of Conserved Candidate Vaccine Antigens in the Surface Proteome of Giardia lamblia.

Authors:  Barbara J Davids; Ching M Liu; Elaine M Hanson; Christine H Y Le; Jonathan Ang; Kurt Hanevik; Marvin Fischer; Matej Radunovic; Nina Langeland; Marcela Ferella; Staffan G Svärd; Majid Ghassemian; Yukiko Miyamoto; Lars Eckmann
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine model.

Authors:  Gabriela Jenikova; Petr Hruz; Mattias K Andersson; Noa Tejman-Yarden; Patricia C D Ferreira; Yolanda S Andersen; Barbara J Davids; Frances D Gillin; Staffan G Svärd; Roy Curtiss; Lars Eckmann
Journal:  Vaccine       Date:  2011-10-12       Impact factor: 3.641

Review 3.  Current status of veterinary vaccines.

Authors:  Els N T Meeusen; John Walker; Andrew Peters; Paul-Pierre Pastoret; Gregers Jungersen
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

4.  Screening for intestinal parasitic infections among Myanmar migrant workers in Thai food industry: a high-risk transmission.

Authors:  Surang Nuchprayoon; Vivornpun Sanprasert; Sakchai Kaewzaithim; Wilai Saksirisampant
Journal:  J Immigr Minor Health       Date:  2008-09-25

Review 5.  Giardia duodenalis: the double-edged sword of immune responses in giardiasis.

Authors:  Shahram Solaymani-Mohammadi; Steven M Singer
Journal:  Exp Parasitol       Date:  2010-06-18       Impact factor: 2.011

6.  Central importance of immunoglobulin A in host defense against Giardia spp.

Authors:  T Dianne Langford; Michael P Housley; Marianne Boes; Jianzhu Chen; Martin F Kagnoff; Frances D Gillin; Lars Eckmann
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

7.  Impact of Giardia vaccination on asymptomatic Giardia infections in dogs at a research facility.

Authors:  Kirsten A Anderson; Andrew S Brooks; Annette L Morrison; Richard J Reid-Smith; S Wayne Martin; Denna M Benn; Andrew S Peregrine
Journal:  Can Vet J       Date:  2004-11       Impact factor: 1.008

8.  Resistance to reinfection in mice as a vaccine model for giardiasis.

Authors:  Erqiu Li; Mingqiu Liu; Steven M Singer
Journal:  Hum Vaccin Immunother       Date:  2014-05-07       Impact factor: 3.452

9.  Changes in the N-glycome, glycoproteins with Asn-linked glycans, of Giardia lamblia with differentiation from trophozoites to cysts.

Authors:  Daniel M Ratner; Jike Cui; Martin Steffen; Landon L Moore; Phillips W Robbins; John Samuelson
Journal:  Eukaryot Cell       Date:  2008-09-26

10.  Treatment of giardiasis: current status and future directions.

Authors:  Richard R Watkins; Lars Eckmann
Journal:  Curr Infect Dis Rep       Date:  2014-02       Impact factor: 3.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.